Cidara Therapeutics Stock (NASDAQ: CDTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 63.369K |
Day Range | - - - |
52 Wk Range | 10.004 - 29.600 |
Market Cap | $54.740M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.87% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cidara Therapeutics (NASDAQ: CDTX) through any online brokerage.
Other companies in Cidara Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS) and CARISMA Therapeutics (NASDAQ:CARM).
The latest price target for Cidara Therapeutics (NASDAQ: CDTX) was reported by Needham on Thursday, May 16, 2024. The analyst firm set a price target for 25.00 expecting CDTX to rise to within 12 months (a possible 108.33% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Cidara Therapeutics (NASDAQ: CDTX) is $12 last updated May 17, 2024 at 8:53 AM EDT.
There are no upcoming dividends for Cidara Therapeutics.
Cidara Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Cidara Therapeutics.
Cidara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.